Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Koenig

Showing results (281-290 of 299) with videos related to

Pageof 30
Sort By:
Plos Pathogens|October 27, 2017
Pegivirus avoids immune recognition but does not attenuate acute-phase disease in a macaque model of HIV infectionAdam L Bailey, Connor R Buechler, Daniel R Matson, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2022
Discovery and SAR of 4-aminopyrrolidine-2-carboxylic acid correctors of CFTR for the treatment of cystic fibrosisMarc J C Scanio, Xenia B Searle, Bo Liu, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Adenosine kinase inhibitors: polar 7-substitutent of pyridopyrimidine derivatives improving their locomotor selectivityGuo Zhu Zheng, Yue Mao, Chih-Hung Lee, et al.
Blood Cancer Discovery|July 9, 2025
An Isoform-Specific RUNX1C-BTG2 Axis Governs AML Quiescence and ChemoresistanceCuijuan Han, Zhiping Zhang, Edie I Crosse, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic FibrosisMarc J C Scanio, Xenia B Searle, Bo Liu, et al.
Plos Pathogens|August 7, 2023
Vertical transmission of African-lineage Zika virus through the fetal membranes in a rhesus macaque (Macaca mulatta) modelMichelle R Koenig, Ann M Mitzey, Xiankun Zeng, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Ultrafast CTCF dynamics control cohesin barrier functionSergei Rudnizky, Peter J Murray, Emily W Sørensen, et al.
Journal of Medicinal Chemistry|June 23, 2007
In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonistsRichard J Perner, Stanley DiDomenico, John R Koenig, et al.
Cell Chemical Biology|October 7, 2025
Discovery of a tau-aggregate clearing compound that covalently targets P4HBLouis P Conway, Michelle A Estrada, Weichao Li, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Pyridopyrimidine analogues as novel adenosine kinase inhibitorsG Z Zheng, C Lee, J K Pratt, et al.
Pageof 30

Showing results (281-290 of 299) with videos related to

Sort By:
Pageof 30
Plos Pathogens|October 27, 2017
Pegivirus avoids immune recognition but does not attenuate acute-phase disease in a macaque model of HIV infectionAdam L Bailey, Connor R Buechler, Daniel R Matson, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2022
Discovery and SAR of 4-aminopyrrolidine-2-carboxylic acid correctors of CFTR for the treatment of cystic fibrosisMarc J C Scanio, Xenia B Searle, Bo Liu, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Adenosine kinase inhibitors: polar 7-substitutent of pyridopyrimidine derivatives improving their locomotor selectivityGuo Zhu Zheng, Yue Mao, Chih-Hung Lee, et al.
Blood Cancer Discovery|July 9, 2025
An Isoform-Specific RUNX1C-BTG2 Axis Governs AML Quiescence and ChemoresistanceCuijuan Han, Zhiping Zhang, Edie I Crosse, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic FibrosisMarc J C Scanio, Xenia B Searle, Bo Liu, et al.
Plos Pathogens|August 7, 2023
Vertical transmission of African-lineage Zika virus through the fetal membranes in a rhesus macaque (Macaca mulatta) modelMichelle R Koenig, Ann M Mitzey, Xiankun Zeng, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Ultrafast CTCF dynamics control cohesin barrier functionSergei Rudnizky, Peter J Murray, Emily W Sørensen, et al.
Journal of Medicinal Chemistry|June 23, 2007
In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonistsRichard J Perner, Stanley DiDomenico, John R Koenig, et al.
Cell Chemical Biology|October 7, 2025
Discovery of a tau-aggregate clearing compound that covalently targets P4HBLouis P Conway, Michelle A Estrada, Weichao Li, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Pyridopyrimidine analogues as novel adenosine kinase inhibitorsG Z Zheng, C Lee, J K Pratt, et al.
Pageof 30